Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
2017 · Molecular Therapy — Methods & Clinical Development · 45 citations
https://doi.org/10.1016/j.omtm.2017.05.003
D
Dwayne L. Barber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
133
Papers
7.0K
Citations
48
h-index
85
i10-index
Dwayne L. Barber is an academic researcher from University of Toronto. The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Chronic Lymphocytic Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 48, co-authored 114 publications.
ORCID: 0000-0001-5528-8150Papers by this author
worksHyperglycemia and reactive oxygen species mediate apoptosis in aortic endothelial cells through Janus kinase 2
2005 · Vascular Pharmacology · 39 citations
https://doi.org/10.1016/j.vph.2005.08.018
Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia
2006 · BMC Genomics · 27 citations
https://doi.org/10.1186/1471-2164-7-138
TRPC3 Activation by Erythropoietin Is Modulated by TRPC6
2008 · Journal of Biological Chemistry · 27 citations
https://doi.org/10.1074/jbc.m804734200
The SH2B1 Adaptor Protein Associates with a Proximal Region of the Erythropoietin Receptor
2012 · Journal of Biological Chemistry · 16 citations
https://doi.org/10.1074/jbc.m112.382721
Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events
2011 · BMC Cancer · 13 citations
https://doi.org/10.1186/1471-2407-11-528
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat